Skip to results
Modify your search
NARROW
1-20 of 106
Authors: Rameen Beroukhim
Sort by
Journal Article
CTIM-28. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT
J Ricardo McFaline-Figueroa and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi.org/10.1093/neuonc/noae165.0361
Published: 11 November 2024
Journal Article
PATH-44. CLINICAL AND RADIOGRAPHIC PREDICTORS OF PROGNOSIS IN ASTROCYTOMA, IDH-MUTANT, WHO GRADE 4
Aleksandra B Lasica and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii188–viii189, https://doi.org/10.1093/neuonc/noae165.0743
Published: 11 November 2024
Journal Article
CTNI-60. SAFETY LEAD-IN RESULTS FOR QBS10072S IN THE INDIVIDUAL SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGHT) TRIAL, A RANDOMIZED ADAPTIVE PLATFORM TRIAL FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA
Rifaquat Rahman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii110, https://doi.org/10.1093/neuonc/noae165.0427
Published: 11 November 2024
Journal Article
DISP-16. EXPLORING SEX-BASED DIFFERENCES IN RESPONSE TO IMMUNOTHERAPY IN GLIOBLASTOMA: A RETROSPECTIVE REVIEW
Catharina Westergaard and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii150, https://doi.org/10.1093/neuonc/noae165.0589
Published: 11 November 2024
Journal Article
Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors
Hia S Ghosh and others
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 195–208, https://doi.org/10.1093/neuonc/noae164
Published: 21 August 2024
Journal Article
ETMR-07. OVEREXPRESSION OF THE PLAG-GENE FAMILY MEMBER PLAG1 DURING MURINE BRAIN DEVELOPMENT LEADS TO ABERRANT EXPRESSION OF IMPRINTED GENES AND THE FORMATION OF MIDLINE BRAIN TUMORS
Jan Vaillant and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.177
Published: 18 June 2024
Journal Article
DIPG-70. NQO1 AS A RESISTANCE DRIVER AND THERAPEUTIC TARGET IN DMG
Leslie E Lupien and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.123
Published: 18 June 2024
Journal Article
DIPG-33. COMBINING CLONAL TRACKING WITH SINGLE CELL RNA SEQUENCING REVEALS TEMPORAL SHIFTS IN CELL STATES ASSOCIATED WITH TRAMETINIB RESISTANCE IN MAPK ALTERED DIFFUSE MIDLINE GLIOMA
Molina Das and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.086
Published: 18 June 2024
Journal Article
LGG-26. A ROLE FOR BRAF FUSION PARTNERS IN ONCOGENIC SIGNALING
Sean Misek and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.419
Published: 18 June 2024
Journal Article
DIPG-05. CHARACTERIZATION OF THE EFFECTS OF H3K27M VARIANTS ON THE DNA-DAMAGE RESPONSE AND TUMOR EVOLUTION IN DIFFUSE MIDLINE GLIOMA
Nicolas Poux and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.059
Published: 18 June 2024
Journal Article
LGG-29. BEYOND MAPK SIGNALING - GENOME-SCALE CRISPR/CAS9 SCREENS REVEAL NEW TARGETS FOR TREATMENT OF KIAA1549::BRAF-DRIVEN PEDIATRIC LOW-GRADE GLIOMA
Anna Borgenvik and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.422
Published: 18 June 2024
Journal Article
LGG-11. UNDERSTANDING THE TRANSCRIPTIONAL HETEROGENEITY OF PEDIATRIC LOW-GRADE GLIOMAS AND ITS IMPLICATION FOR TUMOR PATHOPHYSIOLOGY
Michelle Boisvert and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.404
Published: 18 June 2024
Journal Article
PATH-35. SHIFTS IN GLIOMA PROGNOSTIC MOLECULAR FEATURES ACROSS THE LIFESPAN
Ruchit Patel and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v175–v176, https://doi.org/10.1093/neuonc/noad179.0665
Published: 10 November 2023
Journal Article
CTIM-36. IMMUNOHISTOCHEMISTRY EVALUATION ON PRE-TREATMENT TUMOR TISSUE PREDICTS TREATMENT RESPONSE TO MN-166 (IBUDILAST) AND TEMOZOLOMIDE COMBINATION THERAPY IN GLIOBLASTOMA PATIENTS
Justin Lathia and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v70–v71, https://doi.org/10.1093/neuonc/noad179.0276
Published: 10 November 2023
Journal Article
DDDR-17. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS
Lisa Mayr and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v108–v109, https://doi.org/10.1093/neuonc/noad179.0411
Published: 10 November 2023
Journal Article
RTID-05. SURGICAL WINDOW OF OPPORTUNITY TRIAL REVEALS MECHANISMS OF RESPONSE AND RESISTANCE TO NAVTEMADLIN (KRT-232) IN PATIENTS WITH RECURRENT GLIOBLASTOMA
Veronica Rendo and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v259, https://doi.org/10.1093/neuonc/noad179.0996
Published: 10 November 2023
Journal Article
PATH-12. CONTEMPORARY MOLECULAR LANDSCAPE, SURVIVAL, AND PROGNOSTIC FACTORS IN OVER 4,000 GLIOMAS
Hia Ghosh and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v169, https://doi.org/10.1093/neuonc/noad179.0642
Published: 10 November 2023
Journal Article
DDDR-11. IDENTIFYING NEW VULNERABILITIES TO TARGET PEDIATRIC LOW-GRADE GLIOMA
Anna Borgenvik and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v107, https://doi.org/10.1093/neuonc/noad179.0405
Published: 10 November 2023
Journal Article
DDDR-09. FUNCTIONAL GENOMICS AND CHEMOTHERAPY RESISTANCE SCREENING IDENTIFIES BIOMARKERS AND TARGETABLE MECHANISMS OF CCNU RESISTANCE IN GLIOMAS
Cynthia Hajal and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v106–v107, https://doi.org/10.1093/neuonc/noad179.0403
Published: 10 November 2023
Journal Article
CTNI-17. APPLICATION OF THE GBM-X DATA PLATFORM TO ESTIMATE TREATMENT EFFECTS OF THE EXPERIMENTAL THERAPIES OF THE RANDOMIZED PHASE 2 INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPIES
Rifaquat Rahman and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v76–v77, https://doi.org/10.1093/neuonc/noad179.0299
Published: 10 November 2023
Advertisement
Advertisement